Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hypertension and obstructive sleep apnoea syndrome: current perspectives

Journal of Human Hypertension volume 23, pages 431–443 (2009)Cite this article

Abstract

Obstructive sleep apnoea syndrome (OSAS), due to the collapse of the upper airways, is a common but still underestimated condition. The ‘dose–response’ type relationship between OSAS and hypertension (HT) has now been clearly proven. There are multiple mechanisms explaining this relationship, the main one being an increase in sympathetic activity during the apnoeas. HT associated with OSAS has several characteristics: high prevalence, diastolic and nocturnal predominance, and frequent non-dipper status. Furthermore, as OSAS is found in the majority of subjects with refractory HT, it should be systematically investigated in this situation. HT associated with OSAS should be tested for by means of a clinical blood pressure (BP) measurement, to which 24-h ambulatory BP monitoring (ABPM) is often added due to the fact that BP anomalies are frequently present at night. HT during OSAS is frequently associated with metabolic anomalies (for example, obesity, dyslipidaemia and insulin resistance), therefore explaining the high prevalence of metabolic syndrome in this population. The reference treatment for OSAS—nasal continuous positive airway pressure (nCPAP)—seems to be able to lower the BP of hypertensive patients, especially if the HT is severe, untreated or refractory. Moreover, the BP response to nCPAP depends on the severity of the OSAS, in particular the scale of the nocturnal desaturations, and on patient tolerance of the treatment. Optimal treatment for HT associated with OSAS has not been evidenced. Antihypertensive drugs do not change the respiratory parameters during OSAS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Young T, Peppard PE, Gottlieb DJ . Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217–1239.

    PubMed  Google Scholar 

  2. Gottlieb DJ, Whitney CW, Bonekat WH, Iber C, James GD, Lebowitz M et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999; 159: 502–507.

    CAS  PubMed  Google Scholar 

  3. Baldwin CM, Griffith KA, Nieto FJ, O'Connor GT, Walsleben JA, Redline S . The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001; 24: 96–105.

    CAS  PubMed  Google Scholar 

  4. Veale D, Poussin G, Benes F, Pepin JL, Levy P . Identification of quality of life concerns of patients with obstructive sleep apnoea at the time of initiation of continuous positive airway pressure: a discourse analysis. Qual Life Res 2002; 11: 389–399.

    CAS  PubMed  Google Scholar 

  5. Feuerstein C, Naegelé B, Pépin JL, Lévy P . Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg 1997; 97: 96–107.

    CAS  PubMed  Google Scholar 

  6. Naegele B, Pepin JL, Levy P, Bonnet C, Pellat J, Feuerstein C . Cognitive executive dysfunction in patients with obstructive sleep apnea syndrome (OSAS) after CPAP treatment. Sleep 1998; 21: 392–397.

    CAS  PubMed  Google Scholar 

  7. Mazza S, Pépin JL, Naëgelé B, Plante J, Deschaux C, Lévy P . Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests. Eur Respir J 2005; 25: 75–80.

    CAS  PubMed  Google Scholar 

  8. Leung RS, Bradley TD . Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164: 2147–2165.

    CAS  PubMed  Google Scholar 

  9. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19–25.

    CAS  PubMed  Google Scholar 

  10. Wolk R, Kara T, Somers VK . Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108: 9–12.

    PubMed  Google Scholar 

  11. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746–1752.

    CAS  PubMed  Google Scholar 

  12. Peppard PE, Young T, Palta M, Skatrud J . Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–1384.

    CAS  PubMed  Google Scholar 

  13. Nieto J, Young TB, Lind BK, Shahar E, Samet JM, Redline S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–1836.

    CAS  PubMed  Google Scholar 

  14. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23: 521–527.

    CAS  PubMed  Google Scholar 

  15. Baguet JP, Narkiewicz K, Mallion JM . Update on Hypertension Management: Obstructive sleep apnea and hypertension. J Hypertens 2006; 24: 205–208.

    CAS  PubMed  Google Scholar 

  16. Peker Y, Hedner J, Kraiczi H, Löth S . Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81–86.

    CAS  PubMed  Google Scholar 

  17. Mooe T, Franklin KA, Holmström K, Rabben T, Wiklund U . Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001; 164: 1910–1913.

    CAS  PubMed  Google Scholar 

  18. Milleron O, Pillière R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004; 25: 728–734.

    PubMed  Google Scholar 

  19. Parra O, Arboix A, Bechich S, García-Eroles L, Montserrat JM, López JA et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000; 161: 375–380.

    CAS  PubMed  Google Scholar 

  20. Wessendorf TE, Teschler H, Wang YM, Konietzko N, Thilmann AF . Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000; 247: 41–47.

    CAS  PubMed  Google Scholar 

  21. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD . Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447–1451.

    PubMed Central  PubMed  Google Scholar 

  22. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V . Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034–2041.

    CAS  PubMed  Google Scholar 

  23. Garrigue S, Bordier P, Jaïs P, Shah DC, Hocini M, Raherison C et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002; 346: 404–412.

    PubMed  Google Scholar 

  24. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589–2594.

    PubMed  Google Scholar 

  25. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364–367.

    PubMed  Google Scholar 

  26. Pépin JL, Defaye P, Garrigue S, Poezevara Y, Lévy P . Overdrive atrial pacing does not improve obstructive sleep apnoea syndrome. Eur Respir J 2005; 25: 343–347.

    PubMed  Google Scholar 

  27. Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM . Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 2008; 29: 1662–1669.

    PubMed  Google Scholar 

  28. Partinen M, Jamieson A, Guilleminault C . Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988; 94: 1200–1204.

    CAS  PubMed  Google Scholar 

  29. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149–157.

    CAS  PubMed  Google Scholar 

  30. Veale D, Chailleux E, Hoorelbeke-Ramon A, Reybet-Degas O, Humeau-Chapuis MP, Alluin-Aigouy F et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l′Insuffisance Respiratoire chronique. Eur Respir J 2000; 15: 326–331.

    CAS  PubMed  Google Scholar 

  31. Gami AS, Howard DE, Olson EJ, Somers VK . Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206–1214.

    CAS  PubMed  Google Scholar 

  32. Lavie P, Lavie L, Herer P . All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005; 25: 514–520.

    CAS  PubMed  Google Scholar 

  33. Marin JM, Carrizo SJ, Vicente E, Agusti AG . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.

    PubMed  Google Scholar 

  34. Johns MW . A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–545.

    CAS  PubMed  Google Scholar 

  35. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP . Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485–491.

    CAS  PubMed  Google Scholar 

  36. Weiss JW, Remsburg S, Garpestad E, Ringler J, Sparrow D, Parker JA . Hemodynamic consequences of obstructive sleep apnea. Sleep 1996; 19: 388–397.

    CAS  PubMed  Google Scholar 

  37. Suzuki M, Guilleminault C, Otsuka K, Shiomi T . Blood pressure ‘dipping’ and ‘non-dipping’ in obstructive sleep apnea syndrome patients. Sleep 1996; 19: 382–387.

    CAS  PubMed  Google Scholar 

  38. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997; 15: 1227–1233.

    CAS  PubMed  Google Scholar 

  39. Baguet JP, Lévy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26: 885–892.

    CAS  PubMed  Google Scholar 

  40. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK . Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183–1189.

    CAS  PubMed  Google Scholar 

  41. Lavie L . Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35–51.

    PubMed  Google Scholar 

  42. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y . Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94: 179–184.

    CAS  PubMed  Google Scholar 

  43. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566–570.

    CAS  PubMed  Google Scholar 

  44. Ciftci TU, Kokturk O, Bukan N, Bilgihan A . The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004; 28: 87–91.

    CAS  PubMed  Google Scholar 

  45. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA . Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004; 169: 354–360.

    PubMed  Google Scholar 

  46. Itzhaki S, Lavie L, Pillar G, Tal G, Lavie P . Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 2005; 28: 594–600.

    PubMed  Google Scholar 

  47. Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, Lévy P et al. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 2008; 31: 1046–1053.

    CAS  PubMed  Google Scholar 

  48. Dyugovskaya L, Lavie P, Lavie L . Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934–939.

    PubMed  Google Scholar 

  49. Lavie L, Dyugovskaya L, Lavie P . Sleep-apnea-related intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis 2005; 183: 183–184.

    CAS  PubMed  Google Scholar 

  50. Narkiewicz K, Somers VK . The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15: 1613–1619.

    CAS  PubMed  Google Scholar 

  51. Leuenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C, Sinoway L . Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995; 79: 581–588.

    CAS  PubMed  Google Scholar 

  52. Morgan BJ, Denahan T, Ebert TJ . Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 1993; 74: 2969–2975.

    CAS  PubMed  Google Scholar 

  53. Greenberg HE, Sica A, Batson D, Scharf SM . Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 1999; 86: 298–305.

    CAS  PubMed  Google Scholar 

  54. Ali NJ, Davies RJ, Fleetham JA, Stradling JR . Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep 1991; 14: 163–165.

    CAS  PubMed  Google Scholar 

  55. Davies RJ, Belt PJ, Roberts SJ, Ali NJ, Stradling JR . Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol 1993; 74: 1123–1130.

    CAS  PubMed  Google Scholar 

  56. Smith RP, Veale D, Pépin JL, Lévy PA . Obstructive sleep apnoea and the autonomic nervous system. Sleep Med Rev 1998; 2: 69–92.

    CAS  PubMed  Google Scholar 

  57. Kimoff RJ, Makino H, Horner RL, Kozar LF, Lue F, Slutsky AS et al. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 1994; 76: 1810–1817.

    CAS  PubMed  Google Scholar 

  58. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA . Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106–109.

    CAS  PubMed Central  PubMed  Google Scholar 

  59. Fletcher EC, Lesske J, Qian W, Miller III CC, Unger T . Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992; 19: 555–561.

    CAS  PubMed  Google Scholar 

  60. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG . Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103: 1763–1768.

    CAS  PubMed  Google Scholar 

  61. Somers VK, Dyken ME, Clary MP, Abboud FM . Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897–1904.

    CAS  PubMed Central  PubMed  Google Scholar 

  62. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T . Blood pressure, catecholamines and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (CPAP) treatment. Am J Hypertens 1989; 2: 847–853.

    CAS  PubMed  Google Scholar 

  63. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR . Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993; 103: 722–727.

    CAS  PubMed  Google Scholar 

  64. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J . The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18: 377–381.

    CAS  PubMed  Google Scholar 

  65. Dimsdale JE, Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler MG . Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 1997; 111: 639–642.

    CAS  PubMed  Google Scholar 

  66. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607–2610.

    CAS  PubMed  Google Scholar 

  67. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008; 117: 2270–2278.

    CAS  PubMed Central  PubMed  Google Scholar 

  68. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462–2464.

    CAS  PubMed  Google Scholar 

  69. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP . Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313–1316.

    CAS  PubMed  Google Scholar 

  70. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429–433.

    CAS  PubMed  Google Scholar 

  71. Wilcox CS . Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 2002; 4: 160–166.

    PubMed  Google Scholar 

  72. Cahloun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P . Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40: 892–896.

    Google Scholar 

  73. Moller DS, Lind P, Strunge B, Pedersen EB . Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274–280.

    CAS  PubMed  Google Scholar 

  74. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ . Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obesity Res 1999; 7: 355–362.

    CAS  Google Scholar 

  75. Garrison RJ, Kannel WB, Stokes III J, Castelli WP . Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16: 235–251.

    CAS  PubMed  Google Scholar 

  76. Sheu WH, Lee WJ, Chen YT . High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289–1295.

    CAS  PubMed  Google Scholar 

  77. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK . Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: H234–H237.

    CAS  PubMed  Google Scholar 

  78. Abate N . Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 2000; 14: 154–174.

    CAS  PubMed  Google Scholar 

  79. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK . Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61–66.

    CAS  PubMed  Google Scholar 

  80. Kanagy NL, Walker BR, Nelin LD . Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001; 37: 511–515.

    CAS  PubMed  Google Scholar 

  81. von Känel R, Le DT, Nelesen RA, Mills PJ, Ancoli-Israel S, Dimsdale JE . The hypercoagulable state in sleep apnea is related to comorbid hypertension. J Hypertens 2001; 19: 1445–1451.

    PubMed  Google Scholar 

  82. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000; 160: 2289–2295.

    CAS  PubMed  Google Scholar 

  83. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    CAS  PubMed  Google Scholar 

  84. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–1187.

    Google Scholar 

  85. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB . Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190–195.

    CAS  PubMed  Google Scholar 

  86. Gislason T, Aberg H, Taube A . Snoring and systemic hypertension--an epidemiological study. Acta Med Scand 1987; 222: 415–421.

    CAS  PubMed  Google Scholar 

  87. Carlson JT, Hedner JA, Ejnell H, Peterson LE . High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150: 72–77.

    CAS  PubMed  Google Scholar 

  88. Haas DC, Foster GL, Nieto J, Redline S, Resnick HE, Robbins JA et al. Age-dependent associations between sleep-disordered breathing and hypertension. Importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005; 111: 614–621.

    PubMed  Google Scholar 

  89. Drager LF, Pereira AC, Barreto-Filho JA, Figueiredo AC, Krieger JE, Krieger EM et al. Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 2006; 20: 523–526.

    CAS  PubMed  Google Scholar 

  90. Baguet JP, Hammer L, Lévy P, Pierre H, Launois S, Mallion JM et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005; 128: 3407–3412.

    PubMed  Google Scholar 

  91. Protogerou AD, Laaban JP, Czernichow S, Kostopoulos C, Lekakis J, Safar ME et al. Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. J Hum Hypertens 2008; 22: 415–422.

    CAS  PubMed  Google Scholar 

  92. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC . Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med 1976; 85: 714–719.

    CAS  PubMed  Google Scholar 

  93. Davies CWH, Crosby JH, Mullins RL, Barbour C, Davies RJO, Stradling JR . Case–control study of 24 h ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000; 55: 736–740.

    CAS  PubMed Central  PubMed  Google Scholar 

  94. Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M . Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep cohort Study. Sleep 2008; 31: 795–800.

    PubMed Central  PubMed  Google Scholar 

  95. Grote L, Hedner J, Peter JH . Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 2001; 19: 683–690.

    CAS  PubMed  Google Scholar 

  96. Sharabi Y, Scope A, Chorney N, Grotto I, Dagan Y . Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: Lessons from periodic examination screening. Am J Hypertens 2003; 16: 236–239.

    PubMed  Google Scholar 

  97. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19: 2271–2277.

    CAS  PubMed  Google Scholar 

  98. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I et al. Obstructive sleep apnea and resistant hypertension: a case–control study. Chest 2007; 132: 1858–1862.

    PubMed  Google Scholar 

  99. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510–e526.

    PubMed  Google Scholar 

  100. Lavie P, Hoffstein V . Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 2001; 15: 721–725.

    Google Scholar 

  101. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA . Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131: 453–459.

    CAS  PubMed  Google Scholar 

  102. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

  103. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH . Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735–741.

    PubMed  Google Scholar 

  104. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151–1158.

    CAS  PubMed  Google Scholar 

  105. Ip MSM, Lam KSL, Ho CM, Tsang KWT, Lam WK . Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580–586.

    CAS  PubMed  Google Scholar 

  106. Ip MSM, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL . Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670–676.

    PubMed  Google Scholar 

  107. Harsch IA, Schahin SP, Radespiel-Tröger M, Weintz O, Jahreib H, Fuchs FS et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156–162.

    PubMed  Google Scholar 

  108. Hedner J, Ejnell H, Caidahl K . Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8: 941–946.

    CAS  PubMed  Google Scholar 

  109. Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hedner J . Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001; 19: 2071–2078.

    CAS  PubMed  Google Scholar 

  110. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M . Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995; 107: 1538–1544.

    CAS  PubMed  Google Scholar 

  111. Hedner J, Darpö B, Ejnell H, Carlson J, Caidahl K . Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8: 222–229.

    CAS  PubMed  Google Scholar 

  112. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA . Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077–1083.

    CAS  PubMed  Google Scholar 

  113. Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffmann BB et al. Vascular reactivity in OSA syndrome. Am J Respir Crit Care Med 2000; 161: 187–191.

    CAS  PubMed  Google Scholar 

  114. Bonsignore MR, Parati G, Insalaco GG, Marrone O, Castiglioni P, Romano S et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166: 279–286.

    PubMed  Google Scholar 

  115. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA . Impaired vasodilator responses in obstructive sleep apnea are improved with CPAP therapy. Am J Respir Crit Care Med 2002; 165: 950–953.

    PubMed  Google Scholar 

  116. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129–1134.

    CAS  PubMed  Google Scholar 

  117. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T . Nasal continuous positive airway pressure changes blood pressure ‘non-dippers’ to ‘dippers’ in patients with obstructive sleep apnea. Sleep 1999; 22: 849–853.

    CAS  PubMed  Google Scholar 

  118. Faccenda JF, Mackay TW, Boon NA, Douglas NJ . Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344–348.

    CAS  PubMed  Google Scholar 

  119. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204–210.

    PubMed  Google Scholar 

  120. Börgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Büchner N et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 2004; 17: 1081–1087.

    PubMed  Google Scholar 

  121. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med 2007; 167: 757–765.

    PubMed  Google Scholar 

  122. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185: 67–72.

    CAS  PubMed  Google Scholar 

  123. Bazzano LA, Khan Z, Reynolds K, He J . Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50: 417–423.

    CAS  PubMed  Google Scholar 

  124. Hermida RC, Zamarrón C, Ayala DE, Calvo C . Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit 2004; 9: 193–202.

    PubMed  Google Scholar 

  125. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129: 1459–1467.

    PubMed  Google Scholar 

  126. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241–247.

    CAS  PubMed  Google Scholar 

  127. Martínez-García MA, Gómez-Aldaraví R, Soler-Cataluña JJ, Martínez TG, Bernácer-Alpera B, Román-Sánchez P . Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007; 29: 951–957.

    PubMed  Google Scholar 

  128. Gotsopoulos H, Kelly JJ, Cistulli PA . Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized controlled trial. Sleep 2004; 27: 934–941.

    PubMed  Google Scholar 

  129. Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 656–664.

    PubMed  Google Scholar 

  130. Kraiczi H, Hedner J, Peker Y, Grote L . Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 1423–1428.

    CAS  PubMed  Google Scholar 

  131. Bartel PR, Loock M, Becker P, Robinson E, van der Meyden C, Rossouw S . Short-term antihypertensive medication does not exacerbate sleep-disordered breathing in newly diagnosed hypertensive patients. Am J Hypertens 1997; 10: 640–645.

    CAS  PubMed  Google Scholar 

  132. Grote L, Wutkewicz K, Knaack L, Ploch T, Hedner J, Peter JH . Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am J Hypertens 2000; 13: 1280–1287.

    CAS  PubMed  Google Scholar 

  133. Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J . Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112: 375–383.

    PubMed  Google Scholar 

  134. Barbé F, Mayoralas LR, Duran J, Masa JF, Maimó A, Montserrat JM et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001; 134: 1015–1023.

    PubMed  Google Scholar 

  135. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 773–780.

    PubMed  Google Scholar 

  136. Becker HF, Jerrentrup A, Ploch T, Psych D, Grote L, Penzel T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.

    PubMed  Google Scholar 

  137. Coughlin SR, Mugarza J, Mawdsley L, Wilding J . Continuous positive airway pressure treatment reduces the cardiovascular risk factors associated with obstructive sleep apnea (abstract). Presented at the American Thoracic Society 100th International Conference, May 21–26, 2004, Orlando, FL; C99 Poster: 111.

  138. Dimsdale JE, Loredo JS, Profant J . Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35: 144–147.

    CAS  PubMed  Google Scholar 

  139. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ . Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in ‘non-dippers’. Sleep 1996; 19: 378–381.

    CAS  PubMed  Google Scholar 

  140. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK . Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348–353.

    PubMed  Google Scholar 

  141. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233–1241.

    PubMed  Google Scholar 

  142. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT . Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361–366.

    PubMed  Google Scholar 

  143. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG . Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006; 100: 343–348.

    CAS  PubMed  Google Scholar 

  144. Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbé F et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164: 939–943.

    CAS  PubMed  Google Scholar 

  145. Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-h ambulatory blood pressure. Hypertension 2006; 47: 840–845.

    CAS  PubMed  Google Scholar 

  146. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR . Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229–1235.

    CAS  PubMed  Google Scholar 

  147. Usui K, Bradley TD, Spaak J, Ryan CM, Kubo T, Kaneko Y et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008–2011.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, University Hospital, Grenoble, France

    J-P Baguet & G Barone-Rochette

  2. Bioclinic Radiopharmaceutics Laboratory, INSERM U877, Joseph Fourier University, Grenoble, France

    J-P Baguet

  3. Sleep Laboratory, EFCR, University Hospital, Grenoble, France

    J-L Pépin

  4. HP2 Laboratory (Hypoxia: Pathophysiology), INSERM ERI 17, Joseph Fourier University, Grenoble, France

    J-L Pépin

Authors
  1. J-P Baguet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Barone-Rochette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J-L Pépin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J-P Baguet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baguet, JP., Barone-Rochette, G. & Pépin, JL. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 23, 431–443 (2009). https://doi.org/10.1038/jhh.2008.147

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.147

Keywords

This article is cited by

Search

Advanced search

Quick links